These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
153 related items for PubMed ID: 29702545
1. Steroid Responsive Atypical Hemolytic Uremic Syndrome Triggered by Influenza B Infection. Mittal N, Hartemayer R, Jandeska S, Giordano L. J Pediatr Hematol Oncol; 2019 Jan; 41(1):e63-e67. PubMed ID: 29702545 [Abstract] [Full Text] [Related]
2. Case report - atypical hemolytic uremic syndrome triggered by influenza B. Kobbe R, Schild R, Christner M, Oh J, Loos S, Kemper MJ. BMC Nephrol; 2017 Mar 20; 18(1):96. PubMed ID: 28320387 [Abstract] [Full Text] [Related]
3. Atypical Hemolytic Uremic Syndrome: A Meta-Analysis of Case Reports Confirms the Prevalence of Genetic Mutations and the Shift of Treatment Regimens. Krishnappa V, Gupta M, Elrifai M, Moftakhar B, Ensley MJ, Vachharajani TJ, Sethi SK, Raina R. Ther Apher Dial; 2018 Apr 20; 22(2):178-188. PubMed ID: 29250893 [Abstract] [Full Text] [Related]
4. Isolated thrombotic microangiopathy of the small intestine in a patient with atypical hemolytic uremic syndrome - a case report. Nunius C, Büttner-Herold M, Bertz S, Schiffer M, Buchholz B. BMC Nephrol; 2020 Mar 24; 21(1):104. PubMed ID: 32204691 [Abstract] [Full Text] [Related]
5. Occurrence of atypical HUS associated with influenza B. van Hoeve K, Vandermeulen C, Van Ranst M, Levtchenko E, van den Heuvel L, Mekahli D. Eur J Pediatr; 2017 Apr 24; 176(4):449-454. PubMed ID: 28110418 [Abstract] [Full Text] [Related]
6. Living Donor Kidney Transplantation in Atypical Hemolytic Uremic Syndrome: A Case Series. Duineveld C, Verhave JC, Berger SP, van de Kar NCAJ, Wetzels JFM. Am J Kidney Dis; 2017 Dec 24; 70(6):770-777. PubMed ID: 28821363 [Abstract] [Full Text] [Related]
7. An effective treatment of atypical hemolytic uremic syndrome with plasma exchange and eculizumab: A case report. Sengul Samanci N, Ayer M, Ergen A, Ozturk S. Transfus Apher Sci; 2015 Jun 24; 52(3):314-6. PubMed ID: 25634788 [Abstract] [Full Text] [Related]
8. Distal Angiopathy and Atypical Hemolytic Uremic Syndrome: Clinical and Functional Properties of an Anti-Factor H IgAλ Antibody. Rigothier C, Delmas Y, Roumenina LT, Contin-Bordes C, Lepreux S, Bridoux F, Goujon JM, Bachelet T, Touchard G, Frémeaux-Bacchi V, Combe C. Am J Kidney Dis; 2015 Aug 24; 66(2):331-6. PubMed ID: 26015278 [Abstract] [Full Text] [Related]
9. Efficacy and safety of eculizumab in adult patients with atypical hemolytic uremic syndrome: A single center experience from Turkey. Gediz F, Payzin BK, Ecemis S, Güler N, Yilmaz AF, Topcugil F, Berdeli A. Transfus Apher Sci; 2016 Dec 24; 55(3):357-362. PubMed ID: 27742267 [Abstract] [Full Text] [Related]
10. [Atypical hemolytic uremic syndrome]. Sepúlveda RA, Tagle R, Jara A. Rev Med Chil; 2018 Jun 24; 146(6):770-779. PubMed ID: 30148909 [Abstract] [Full Text] [Related]
11. Eculizumab Modifies Outcomes in Adults with Atypical Hemolytic Uremic Syndrome with Acute Kidney Injury. Cao M, Leite BN, Ferreiro T, Calvo M, Fernández C, Alonso Á, Rodriguez A, Salvador P, Seijo R, Pita S, Arjona E, Rodríguez de Córdoba S, Valdés Cañedo F. Am J Nephrol; 2018 Jun 24; 48(3):225-233. PubMed ID: 30205388 [Abstract] [Full Text] [Related]
12. Innovative therapeutic approach: sequential treatment with plasma exchange and eculizumab in a pregnant woman affected by atypical hemolytic-uremic syndrome. Mussoni MP, Veneziano FA, Boetti L, Tassi C, Calisesi C, Nucci S, Rigotti A, Panzini I, Ardissino G. Transfus Apher Sci; 2014 Oct 24; 51(2):134-6. PubMed ID: 25294113 [Abstract] [Full Text] [Related]
13. Atypical hemolytic uremic syndrome: a case report. Basnayake BMDB, Wazil AWM, Nanayakkara N, Samarakoon SMDK, Senavirathne EMSK, Thangarajah BUEWDR, Karunasena N, Mahanama RMBSS. J Med Case Rep; 2020 Jan 13; 14(1):11. PubMed ID: 31928535 [Abstract] [Full Text] [Related]
14. Atypical Hemolytic-Uremic Syndrome: An Update on Pathophysiology, Diagnosis, and Treatment. Raina R, Krishnappa V, Blaha T, Kann T, Hein W, Burke L, Bagga A. Ther Apher Dial; 2019 Feb 13; 23(1):4-21. PubMed ID: 30294946 [Abstract] [Full Text] [Related]
15. A retrospective study of pregnancy-associated atypical hemolytic uremic syndrome. Huerta A, Arjona E, Portoles J, Lopez-Sanchez P, Rabasco C, Espinosa M, Cavero T, Blasco M, Cao M, Manrique J, Cabello-Chavez V, Suñer M, Heras M, Fulladosa X, Belmar L, Sempere A, Peralta C, Castillo L, Arnau A, Praga M, Rodriguez de Cordoba S. Kidney Int; 2018 Feb 13; 93(2):450-459. PubMed ID: 28911789 [Abstract] [Full Text] [Related]
16. Relapse of Atypical Hemolytic Uremic Syndrome During Pregnancy in a Patient on Eculizumab Maintenance Treatment: A Case Report. Fontana F, Alfano G, Bardhushi E, Ligabue G, Giovanella S, Neri I, Cappelli G. Am J Case Rep; 2019 Oct 04; 20():1460-1465. PubMed ID: 31582717 [Abstract] [Full Text] [Related]
17. Atypical Hemolytic Uremic Syndrome. Dixon BP, Gruppo RA. Pediatr Clin North Am; 2018 Jun 04; 65(3):509-525. PubMed ID: 29803280 [Abstract] [Full Text] [Related]
18. Terminal Complement Inhibitor Eculizumab in Adult Patients With Atypical Hemolytic Uremic Syndrome: A Single-Arm, Open-Label Trial. Fakhouri F, Hourmant M, Campistol JM, Cataland SR, Espinosa M, Gaber AO, Menne J, Minetti EE, Provôt F, Rondeau E, Ruggenenti P, Weekers LE, Ogawa M, Bedrosian CL, Legendre CM. Am J Kidney Dis; 2016 Jul 04; 68(1):84-93. PubMed ID: 27012908 [Abstract] [Full Text] [Related]
19. Eculizumab is a safe and effective treatment in pediatric patients with atypical hemolytic uremic syndrome. Greenbaum LA, Fila M, Ardissino G, Al-Akash SI, Evans J, Henning P, Lieberman KV, Maringhini S, Pape L, Rees L, van de Kar NC, Vande Walle J, Ogawa M, Bedrosian CL, Licht C. Kidney Int; 2016 Mar 04; 89(3):701-11. PubMed ID: 26880462 [Abstract] [Full Text] [Related]
20. Severe and malignant hypertension are common in primary atypical hemolytic uremic syndrome. Cavero T, Arjona E, Soto K, Caravaca-Fontán F, Rabasco C, Bravo L, de la Cerda F, Martín N, Blasco M, Ávila A, Huerta A, Cabello V, Jarque A, Alcázar C, Fulladosa X, Carbayo J, Anaya S, Cobelo C, Ramos N, Iglesias E, Baltar J, Martínez-Gallardo R, Pérez L, Morales E, González R, Macía M, Draibe J, Pallardó L, Quintana LF, Espinosa M, Barros X, Pereira F, Cao M, Moreno JA, Rodríguez de Córdoba S, Praga M, Spanish Group for the Study of Glomerular Diseases (GLOSEN). Kidney Int; 2019 Oct 04; 96(4):995-1004. PubMed ID: 31420192 [Abstract] [Full Text] [Related] Page: [Next] [New Search]